Demands from payors and regulators for differentiated products necessitates creative integration of available data/information, with future trial data, to accelerate drug development in an efficient, cost effective and ethical manner.
Drug development moves at a swift pace in an ever-changing competitive landscape and project teams are constantly facing new challenges, demanding a proactive and adaptive mindset.
Scientific rigor, quality, compliance and traceability are cornerstones in clinical drug development and regulatory submissions. This requires reliable technical solutions and experience to efficiently leverage MIDD in these settings.
Latest news from Pharmetheus
We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses delivered during the first half of 2021. What a pleasure it was to learn from our PBPK experts as they reprised the workshop they offered to FDA. Our newcomers in particular appreciated the broadening of their awareness of, and skill set in, a highly complementary quantitative approach.
Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.
If you are interested in our services, please fill out the form below.
Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.